Vote Scores
Filings read through

Rhythm Pharmaceuticals, Inc.: how funds voted at the meeting of 24 Jun 2026

Ticker
RYTM
Meeting
Season
year to 30 June 2026
Filers reporting
461
Ballot items
3

461 filers on Form N-PX reported votes at the Rhythm Pharmaceuticals, Inc. meeting of 24 Jun 2026. The records fall into 3 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    2 nominees. 75.2% of the reported votes are for. 75 filers withheld from or voted against at least one nominee.

    636 vote records from 168 filers. 8 of the 167 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 45 fund families
    • For 30
    • Abstain or withhold 3
    • Split or no vote 12
    • Against management 3
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    684 vote records from 460 filers. 193 of the 444 filers that marked the item voted against management. 16 filers gave no management mark.

    • Positions of 48 fund families
    • For 28
    • Against 19
    • Split or no vote 1
    • Against management 19
  3. Item 3: Audit-related items (auditor ratification)

    318 vote records from 168 filers. 1 of the 167 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 45 fund families
    • For 44
    • Split or no vote 1

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Rhythm Pharmaceuticals, Inc., meeting of 24 Jun 2026Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Auditor
AllianceBernsteinForFor
AllspringSplitSplit
American CenturyAgainst, against managementNo report
Artisan PartnersAgainst, against managementNo report
BlackRock and iSharesForFor
BNY MellonAgainst, against managementFor
Brighthouse FundsForFor
Capital Group and American FundsAgainst, against managementFor
Charles SchwabForFor
Columbia ThreadneedleAgainst, against managementFor
DimensionalAgainst, against managementNo report
DWSAgainst, against managementFor
EquitableForFor
Federated HermesForFor
FidelityForFor
First TrustAgainst, against managementFor
Franklin TempletonAgainst, against managementFor
Global XForFor
Goldman SachsForFor
Guggenheim and RydexAgainst, against managementFor
Harbor FundsAgainst, against managementFor
InvescoAgainst, against managementFor
J.P. MorganForFor
Jackson National fundsForFor
Janus HendersonForFor
John Hancock and ManulifeAgainst, against managementFor
Lincoln FinancialForFor
Lord AbbettForFor
MassMutualAgainst, against managementFor
Morgan Stanley, Eaton Vance and CalvertAgainst, against managementFor
NationwideForFor
Natixis and Loomis SaylesForFor
Neuberger BermanForFor
Northern Trust and FlexSharesAgainst, against managementFor
Nuveen and TIAAForFor
Pacific Life fundsForFor
PGIM and PrudentialForFor
PrincipalForFor
ProShares and ProFundsAgainst, against managementFor
Russell InvestmentsForFor
SEIForFor
State Street and SPDRForFor
T. Rowe PriceForFor
TransamericaForFor
VanguardForFor
Victory CapitalAgainst, against managementFor
VirtusAgainst, against managementFor
VoyaForFor

Questions

How many filers reported votes at the Rhythm Pharmaceuticals, Inc. meeting?
461 Form N-PX filers reported votes at the meeting of 24 Jun 2026. On say-on-pay, 193 of 444 filers that marked the item voted against management (43.5%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Rhythm Pharmaceuticals, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Rhythm Pharmaceuticals, Inc. with a meeting date within three days of 24 Jun 2026. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .